rs712830
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 0 | common in clinvar |
Make rs712830(A;C) |
Make rs712830(C;C) |
Reference | GRCh38 38.1/141 |
Chromosome | 7 |
Position | 55019087 |
Gene | EGFR, LOC105375284 |
is a | snp |
is | mentioned by |
dbSNP | rs712830 |
dbSNP (classic) | rs712830 |
ClinGen | rs712830 |
ebi | rs712830 |
HLI | rs712830 |
Exac | rs712830 |
Gnomad | rs712830 |
Varsome | rs712830 |
LitVar | rs712830 |
Map | rs712830 |
PheGenI | rs712830 |
Biobank | rs712830 |
1000 genomes | rs712830 |
hgdp | rs712830 |
ensembl | rs712830 |
geneview | rs712830 |
scholar | rs712830 |
rs712830 | |
pharmgkb | rs712830 |
gwascentral | rs712830 |
openSNP | rs712830 |
23andMe | rs712830 |
SNPshot | rs712830 |
SNPdbe | rs712830 |
MSV3d | rs712830 |
GWAS Ctlg | rs712830 |
GMAF | 0.1111 |
Max Magnitude | 0 |
[PMID 17875215] Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
[PMID 17956637] Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
[PMID 19102716] EGFR-targeted therapies in lung cancer: predictors of response and toxicity.
ClinVar | |
---|---|
Risk | rs712830(C;C) |
Alt | rs712830(C;C) |
Reference | Rs712830(A;A) |
Significance | Probable-non-pathogenic |
Disease | Lung cancer |
Variation | info |
Gene | EGFR |
CLNDBN | Lung cancer |
Reversed | 0 |
HGVS | NC_000007.13:g.55086780A>C |
CLNSRC | |
CLNACC | RCV000262345.1, |
[PMID 30011810] The Association between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk.